Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Intravitreal thalidomide reduces experimental preretinal neovascularization without induction of retinal toxicity.

    Vom Hagen F, Kamppeter BA, Erber R, Jonas J, Hammes HP.

    Br J Ophthalmol. 2009 Aug 27. [Epub ahead of print]PMID: 19713194 [PubMed - as supplied by publisher]Related articles

    2.

    Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.

    Kamppeter BA, Cej A, Jonas JB.

    Ophthalmology. 2008 Aug;115(8):1372-5. Epub 2008 Mar 20.PMID: 18355920 [PubMed - indexed for MEDLINE]Related articles

    3.

    Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.

    Jonas JB, Strueven V, Kamppeter BA, Harder B, Spandau UH, Schlichtenbrede F.

    J Ocul Pharmacol Ther. 2006 Oct;22(5):370-6.PMID: 17076632 [PubMed - indexed for MEDLINE]Related articles

    4.

    Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration.

    Jonas JB, Harder B, Spandau UH, Kamppeter BA, Libondi T, Sauder G.

    Eur J Ophthalmol. 2006 Sep-Oct;16(5):774-5.PMID: 17061237 [PubMed - indexed for MEDLINE]Related articles

    5.

    Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.

    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

    Ophthalmic Res. 2006;38(6):324-8. Epub 2006 Oct 13.PMID: 17047404 [PubMed - indexed for MEDLINE]Related articles

    6.

    Further investigation of the tolerance and mechanical adjustability of the *Acri.Tec AR-1 PC/IOL in rabbit eyes: an intraocular lens with reversibly adjustable optical power.

    Jahn CE, Fromberg I, Fesser N, Allgoewer I, Jahn CH, Wakili NS, Hofmann-Rummelt CR, Holbach LM, Kamppeter BA.

    Ophthalmic Res. 2006;38(5):309-12. Epub 2006 Sep 15.PMID: 16974133 [PubMed - indexed for MEDLINE]Related articles

    7.

    Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema.

    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

    Eur J Ophthalmol. 2006 Jul-Aug;16(4):566-72.PMID: 16952096 [PubMed - indexed for MEDLINE]Related articles

    8.

    Triamcinolone acetonide-induced ocular hypertension.

    Jonas JB, Sauder G, Budde WM, Spandau UH, Kamppeter BA, Harder B.

    J Ocul Pharmacol Ther. 2006 Aug;22(4):247-50.PMID: 16910865 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study.

    Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH.

    J Ocul Pharmacol Ther. 2006 Jun;22(3):200-7.PMID: 16808682 [PubMed - indexed for MEDLINE]Related articles

    10.

    Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.

    Jonas JB, Spandau UH, Kamppeter BA, Degenring RF, Kreissig I, Akkoyun I, Vossmerbaeumer U.

    J Ocul Pharmacol Ther. 2006 Jun;22(3):194-9.PMID: 16808681 [PubMed - indexed for MEDLINE]Related articles

    11.

    Optical coherence tomography of the optic nerve head: interindividual reproducibility.

    Kamppeter BA, Schubert KV, Budde WM, Degenring RF, Jonas JB.

    J Glaucoma. 2006 Jun;15(3):248-54.PMID: 16778649 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Acute vision loss in oculus ultimus]

    Kamppeter BA, Jonas JB, Degenring RF.

    Ophthalmologe. 2007 May;104(5):418-21. German. No abstract available. PMID: 16738873 [PubMed - indexed for MEDLINE]Related articles

    13.

    Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.

    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.

    Ophthalmology. 2006 May;113(5):800-4. Epub 2006 Mar 13.PMID: 16530840 [PubMed - indexed for MEDLINE]Related articles

    14.

    Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.

    Jonas JB, Spandau UH, Kamppeter BA, Harder B.

    Eye (Lond). 2007 Mar;21(3):387-94. Epub 2006 Jan 13.PMID: 16410809 [PubMed - indexed for MEDLINE]Related articles

    15.

    Dynamic contour tonometry for intraocular pressure measurement.

    Kamppeter BA, Jonas JB.

    Am J Ophthalmol. 2005 Aug;140(2):318-20.PMID: 16086958 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Fluctuations depending on time of day in measurements of the optic disc using confocal laser canning tomography]

    Kamppeter BA, Jonas JB.

    Ophthalmologe. 2006 Jan;103(1):40-2. German. PMID: 16047151 [PubMed - indexed for MEDLINE]Related articles

    17.

    Contrast and glare sensitivity after implantation of AcrySof and Human Optics 1CU intraocular lenses.

    Kamppeter BA, Sauder G, Jonas JB.

    Eur J Ophthalmol. 2005 Jul-Aug;15(4):458-61.PMID: 16001377 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

    Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.

    Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA.

    Ophthalmology. 2005 Apr;112(4):593-8.PMID: 15808249 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal triamcinolone acetonide and central serous chorioretinopathy.

    Jonas JB, Kamppeter BA.

    Br J Ophthalmol. 2005 Mar;89(3):386-7. No abstract available. PMID: 15722324 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Harder B, Kamppeter BA.

    Am J Ophthalmol. 2004 Dec;138(6):970-7.PMID: 15629288 [PubMed - indexed for MEDLINE]Related articles

    22.

    Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.

    Jonas JB, Kreissig I, Degenring RF, Kamppeter BA.

    Br J Ophthalmol. 2005 Jan;89(1):122. No abstract available. PMID: 15615762 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide.

    Jonas JB, Vossmerbaeumer U, Kamppeter BA.

    Acta Ophthalmol Scand. 2004 Oct;82(5):637. No abstract available. PMID: 15453876 [PubMed - indexed for MEDLINE]Related articles

    24.

    Optical coherence tomography of a peripheral retinal schisis with an outer retinal layer break.

    Kamppeter BA, Jonas JB.

    Acta Ophthalmol Scand. 2004 Oct;82(5):574-5. No abstract available. PMID: 15453856 [PubMed - indexed for MEDLINE]Related articles

    25.

    Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

    Jonas JB, Degenring RF, Kamppeter BA, Kreissig I, Akkoyun I.

    Am J Ophthalmol. 2004 Jul;138(1):158-60.PMID: 15234306 [PubMed - indexed for MEDLINE]Related articles

    26.

    Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.

    Jonas JB, Degenring RF, Kamppeter BA.

    J Glaucoma. 2004 Jun;13(3):261. No abstract available. PMID: 15118474 [PubMed - indexed for MEDLINE]Related articles

    27.

    Intraocular lens with reversibly adjustable optical power: pilot study of concept and safety.

    Jahn CE, Jahn MA, Kreiner CF, Serester A, Fromberg I, Jacobi S, Deutschmann S, Schäffer EH, Kamppeter BA.

    J Cataract Refract Surg. 2003 Sep;29(9):1795-9.PMID: 14522304 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...